Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions (Englisch)
- Neue Suche nach: Ponnusamy, Lavanya
- Neue Suche nach: Natarajan, Sathan Raj
- Neue Suche nach: Thangaraj, Karthik
- Neue Suche nach: Manoharan, Ravi
- Neue Suche nach: Ponnusamy, Lavanya
- Neue Suche nach: Natarajan, Sathan Raj
- Neue Suche nach: Thangaraj, Karthik
- Neue Suche nach: Manoharan, Ravi
In:
Biochimica et Biophysica Acta - Reviews on Cancer
;
1874
, 1
;
2020
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions
-
Beteiligte:Ponnusamy, Lavanya ( Autor:in ) / Natarajan, Sathan Raj ( Autor:in ) / Thangaraj, Karthik ( Autor:in ) / Manoharan, Ravi ( Autor:in )
-
Erschienen in:
-
Verlag:
- Neue Suche nach: Elsevier B.V.
-
Erscheinungsdatum:10.05.2020
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:Breast cancer , AMPK , AMPK activator , Synthetic compounds , Natural compounds , AMP-activated protein kinase , AMP , Adenosine monophosphate , ADP , Adenosine diphosphate , ATP , Adenosine triphosphate , CaMKKβ , Ca2C/calmodulin-dependent PK kinase β , LKB-1 , Liver kinase B1 , TAK1 , TGFβ Activated Kinase1 , mTOR , mammalian target of rapamycin , MDMX , Murine Double Minute X , TBC1D1 , TBC domain family, member 1 , TXNIP , thioredoxin-interacting protein , GLUT , Glucose transporter , PFKFB3 , 6-phosphofructo- 2-kinase/fructose-2, 6-biphosphatase , ACC , Acetyl-CoA carboxylase , CPT , Carnitine palmitoyltransferase , HMGCR , 3-hydroxy-3-methyl-glutaryl-CoA reductase , HSL , hormone-sensitive lipase , Cox2 , Cyclooxygenase-2 , LK1 , unc-51-like autophagy-activating kinase 1 , EGFR , Epidermal growth factor receptor , HER2 , human epidermal growth factor receptor 2 , DVL , Disheveled segment polarity protein , PI3K , Phosphoinositide 3-kinases , TSC , Tuberous sclerosis proteins , PDE3B , Phosphodiesterase 3B , TGFβ , Transforming growth factor β , EMT , Epithelial-Mesenchymal transition , IGF1R , Insulin-like growth factor 1 Receptor , ErbB2 , Erythroblastic oncogene B , ERK , Extracellular regulated kinases , AICAR , 5-aminoimidazole-4-carboxamide ribonucleotide , TNBC , Triple-negative Breast cancer , MTDH , Metadherin , GSK-3β , Glycogen synthase kinase-3β , SIRT1 , Sirtuin 1 , PPAR , Peroxisome proliferator-activated receptor , FASN , Fatty acid synthase , PGC-1αA , Peroxisome proliferator-activated receptor gamma coactivator1-alpha , NRF1 , Nuclear respiratory factor 1 , mtTFA , Mitochondrial transcription factor , HIF-1α , Hypoxia Inducible Factor-1α , MDM2 , Murine Double Minute 2 homolog , NSAID , Nonsteroidal anti-inflammatory drugs , PLK2 , polo like kinase2 , NDGA , Nordihydroguaiaretic acid , VEGF , Vascular Endothelial Growth Factor , DMC , Demothoxycurcumin , PP2A , Protein Phosphatase 2A
-
Datenquelle:
Inhaltsverzeichnis – Band 1874, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
-
Gambogic acid: A shining natural compound to nanomedicine for cancer therapeuticsHatami, Elham / Jaggi, Meena / Chauhan, Subhash C. / Yallapu, Murali M. et al. | 2020
-
Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patientsMuniyan, Sakthivel / Xi, Lei / Datta, Kaustubh / Das, Anindita / Teply, Benjamin A. / Batra, Surinder K. / Kukreja, Rakesh C. et al. | 2020
-
Immunomodulatory effects of ablation therapy on tumors: Potentials for combination with immunotherapyQian, Ling / Shen, Yehua / Xie, Jing / Meng, Zhiqiang et al. | 2020
-
Bacteria as a double-action sword in cancerYaghoubi, Atieh / Khazaei, Majid / Jalili, Saba / Hasanian, Seyed Mahdi / Avan, Amir / Soleimanpour, Saman / Cho, William C. et al. | 2020
-
Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapyZhao, Yan / Zhang, Ya-Ni / Wang, Kai-Ting / Chen, Lei et al. | 2020
-
PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERPRoberts, Owain / Paraoan, Luminita et al. | 2020
-
Emerging functions and clinical prospects of connexins and pannexins in melanomaVarela-Vázquez, Adrián / Guitián-Caamaño, Amanda / Carpintero-Fernandez, Paula / Fonseca, Eduardo / Sayedyahossein, Samar / Aasen, Trond / Penuela, Silvia / Mayán, María D. et al. | 2020
-
Extracellular vesicle-based liquid biopsy holds great promise for the management of ovarian cancerZheng, Xiaocui / Li, Xiaoduan / Wang, Xipeng et al. | 2020
-
Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directionsPonnusamy, Lavanya / Natarajan, Sathan Raj / Thangaraj, Karthik / Manoharan, Ravi et al. | 2020
-
ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumorsBiswas, Angana / Rajesh, Yetirajam / Mitra, Pralay / Mandal, Mahitosh et al. | 2020
-
Enzyme-based autophagy in anti-neoplastic management: From molecular mechanisms to clinical therapeuticsAjoolabady, Amir / Aghanejad, Ayuob / Bi, Yaguang / Zhang, Yingmei / Aslkhodapasandhukmabad, Hamid / Abhari, Alireza / Ren, Jun et al. | 2020
-
CRISPR screen in mechanism and target discovery for cancer immunotherapyLiu, Dan / Zhao, Xuan / Tang, Anqun / Xu, Xiyue / Liu, Shuci / Zha, Li / Ma, Wen / Zheng, Junnian / Shi, Ming et al. | 2020
-
Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenalMundry, Clara S. / Eberle, Kirsten C. / Singh, Pankaj K. / Hollingsworth, Michael A. / Mehla, Kamiya et al. | 2020
-
Editorial Board| 2020
-
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor typesvan den Ende, Tom / van den Boorn, Héctor G. / Hoonhout, Nadine M. / van Etten-Jamaludin, Faridi S. / Meijer, Sybren L. / Derks, Sarah / de Gruijl, Tanja D. / Bijlsma, Maarten F. / van Oijen, Martijn G.H. / van Laarhoven, Hanneke W.M. et al. | 2020
-
Killing the “BAD”: Challenges for immunotherapy in pancreatic cancerLi, Tian-Jiao / Wang, Wen-Quan / Yu, Xian-Jun / Liu, Liang et al. | 2020
-
FOX transcription factor family in hepatocellular carcinomaGong, Zhongqin / Yu, Jianqing / Yang, Shucai / Lai, Paul B.S. / Chen, George G. et al. | 2020
-
Cholesterol metabolism: New functions and therapeutic approaches in cancerXu, Huanji / Zhou, Sheng / Tang, Qiulin / Xia, Hongwei / Bi, Feng et al. | 2020
-
Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challengesYan, Jie / Yu, Shuangni / Jia, Congwei / Li, Min / Chen, Jie et al. | 2020
-
Nucleic acid nanotechnology for cancer treatmentJin, Jun-O / Kim, Gyurin / Hwang, Juyoung / Han, Kyung Ho / Kwak, Minseok / Lee, Peter C.W. et al. | 2020
-
New insights on sorafenib resistance in liver cancer with correlation of individualized therapyCheng, Zhang / Wei-Qi, Jiang / Jin, Ding et al. | 2020
-
Emerging roles of HSF1 in cancer: Cellular and molecular episodesWang, Ge / Cao, Pengxiu / Fan, Yumei / Tan, Ke et al. | 2020
-
Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progressionLiao, Zhenyu / Jiang, Wang / Ye, Longyun / Li, Tianjiao / Yu, Xianjun / Liu, Liang et al. | 2020